Skip to main content

Does minoxidil really work for women’s hair loss?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on June 26, 2025.

Official Answer by Drugs.com

Yes—topical minoxidil is the only FDA-approved medicine for female pattern hair loss. Up to 60% of patients regrow noticeably thicker hair after eight months of daily use (2% solution twice daily or 5% foam once daily). Consistency and early treatment are key; for best results, always consult a clinician first.

Evidence for Topical Minoxidil Use in Women

Clinical trials established minoxidil’s efficacy in women with female pattern hair loss (FPHL):

Which Strength and Formulation?

Choosing the right strength and formulation of minoxidil (brand name: Women's Rogaine) is an important step in achieving the best results for women’s hair loss. With options ranging from the original 2% solution to the newer 5% foam, and even oral formulations for select cases, understanding the differences can help tailor treatment to individual needs, preferences, and tolerances.

How to Use Minoxidil Correctly

Minoxidil comes in different formulations over the counter, such as a topical solution and foam. The foam is indicated for once-daily use, whereas the solution is recommended to be applied twice a day. Below is a general guide on how to apply minoxidil correctly, but make sure to always follow the directions on your specific minoxidil product or from your healthcare provider.

Step-by-step guide:

  1. Apply the amount specified on the package or by your healthcare provider to the hair loss areas on a dry scalp, parting hair to reach thinning areas.
  2. Wash your hands well after applying.
  3. Allow the solution or foam to dry before styling or bedtime. This may take a few hours for the solution, while the foam tends to dry faster.
  4. Expect increased shedding in the first 4–6 weeks—this is temporary.
  5. Assess results at six months; continued use is necessary to maintain benefits.

When Will You See Results?

Everyone responds differently to minoxidil treatment. However, most people tend to follow the following timeline:

Safety and Side Effects

Most side effects of minoxidil occur near the area where it is applied, and may include itching, scalp irritation, rash, temporary hair shedding, and unwanted facial hair. Systemic side effects are rare with topical use of minoxidil, but dizziness, low blood pressure, and rapid heartbeat are possible.

Because of the potential for minoxidil to cause harm to babies, it is not recommended for pregnant or breastfeeding women.

Who Should (and Should Not) Use Minoxidil

Not everyone is an ideal candidate for minoxidil, and using it safely means understanding who should—and should not—consider this treatment. While minoxidil is FDA-approved for women 18 and older with hereditary hair thinning on the scalp, certain health conditions, life stages, and scalp issues can make its use unsafe or ineffective.

Your healthcare provider can discuss the risks and benefits of using minoxidil for hair loss with you and help you determine if it is the best treatment option.

Advantages and Disadvantages of Minoxidil for Hair Loss

Like most medications, there are pros and cons to using minoxidil for hair loss.

Pros

Cons

Alternatives and Adjunct Treatments for Hair Loss

While minoxidil is the only FDA-approved topical treatment for female-pattern hair loss, it’s not the only option available. For women who don’t respond to minoxidil, experience side effects, or want to maximize results, several alternative and adjunct therapies exist. These range from oral medications to innovative procedures and at-home devices—each with its own evidence base, benefits, and considerations.

Key Takeaways

This is not all the information you need to know about minoxidil for safe and effective use and does not take the place of your doctor’s directions. Review the full patient medication guide and discuss this information and any questions you have with your doctor or other health care provider.

References
  1. Aleissa M. (2023). The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Cureus, 15(8), e43559. https://doi.org/10.7759/cureus.43559
  2. Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014 Feb;46(2):144-51. doi: 10.1002/lsm.22170. Epub 2013 Aug 23. PMID: 23970445; PMCID: PMC3944668.
  3. Boersma, I. H., Oranje, A. P., Grimalt, R., Iorizzo, M., Piraccini, B. M., & Verdonschot, E. H. (2014). The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian journal of dermatology, venereology and leprology, 80(6), 521–525. https://doi.org/10.4103/0378-6323.144162
  4. DeVillez, R. L., Jacobs, J. P., Szpunar, C. A., & Warner, M. L. (1994). Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Archives of dermatology, 130(3), 303–307. PMID: 8129407
  5. Gogtay, J. A., & Panda, M. (2009). Minoxidil topical foam: a new kid on the block. International journal of trichology, 1(2), 142. https://doi.org/10.4103/0974-7753.58560
  6. Gupta, A. K., Quinlan, E. M., Venkataraman, M., & Bamimore, M. A. (2022). Microneedling for Hair Loss. Journal of cosmetic dermatology, 21(1), 108–117. https://doi.org/10.1111/jocd.14525
  7. Harvard Health Publishing. (n.d.). Treating female pattern hair loss. Accessed on June 26, 2025 at https://www.health.harvard.edu/staying-healthy/treating-female-pattern-hair-loss
  8. Kobayashi, S., Rose, L., Minta, A., Trovato, S., & Dulmage, B. (2025). Comparing Adherence, Side Effects, and Satisfaction in Oral and Topical Minoxidil: A Cross-Sectional Study. Journal of drugs in dermatology : JDD, 24(2), 131–133. https://doi.org/10.36849/JDD.8424
  9. Iamsumang, W., Leerunyakul, K., & Suchonwanit, P. (2020). Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. Drug design, development and therapy, 14, 951–959. https://doi.org/10.2147/DDDT.S240615
  10. Lachgar, S., Charveron, M., Gall, Y., & Bonafe, J. L. (1998). Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. The British journal of dermatology, 138(3), 407–411. https://doi.org/10.1046/j.1365-2133.1998.02115.x
  11. Lucky, A. W., Piacquadio, D. J., Ditre, C. M., Dunlap, F., Kantor, I., Pandya, A. G., Savin, R. C., & Tharp, M. D. (2004). A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 50(4), 541–553. https://doi.org/10.1016/j.jaad.2003.06.014
  12. Müller Ramos, P., Melo, D. F., Radwanski, H., de Almeida, R. F. C., & Miot, H. A. (2023). Female-pattern hair loss: therapeutic update. Anais brasileiros de dermatologia, 98(4), 506–519. https://doi.org/10.1016/j.abd.2022.09.006
  13. Nobari NN, Roohaninasab M, Sadeghzadeh-Bazargan A, et al. 2023. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia. Adv Clin Exp Med. https://doi.org/10.17219/acem/157990
  14. Paichitrojjana, A., & Paichitrojjana, A. (2022). Platelet Rich Plasma and Its Use in Hair Regrowth: A Review. Drug design, development and therapy, 16, 635–645. https://doi.org/10.2147/DDDT.S356858
  15. Patel P, Nessel TA, Kumar D D. Minoxidil. [Updated 2023 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Accessed on June 26, 2025 at https://www.ncbi.nlm.nih.gov/books/NBK482378/
  16. Ramírez-Marín, H. A., & Tosti, A. (2022). Role of Oral Minoxidil in Patterned Hair Loss. Indian dermatology online journal, 13(6), 729–733. https://doi.org/10.4103/idoj.idoj_246_22
  17. Rogaine. Frequently Asked Questions. Accessed on June 26, 2025 at https://www.rogaine.com/collections/womens-products
  18. U. S. Food and Drug Administration. 2021. Microneedling Devices: Getting to the Point on Benefits, Risks and Safety. Accessed on June 26, 2025 at https://www.fda.gov/consumers/consumer-updates/microneedling-devices-getting-point-benefits-risks-and-safety
  19. van Zuuren, E. J., Fedorowicz, Z., & Schoones, J. (2016). Interventions for female pattern hair loss. The Cochrane database of systematic reviews, 2016(5), CD007628. https://doi.org/10.1002/14651858.CD007628.pub4
  20. Wall, D., Meah, N., Fagan, N., York, K., & Sinclair, R. (2022). Advances in hair growth. Faculty reviews, 11, 1. https://doi.org/10.12703/r/11-1
  21. Womens Rogaine Unscented - minoxidil foam [package insert]. Updated November 2024. Kenvue Brands LLC. Accessed on June 26, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d328537-b7f5-43cc-9837-c5a0c6c390f8
  22. Womens Rogaine Unscented - minoxidil solution [package insert]. Updated September 2024. Kenvue Brands LLC. Accessed on June 26, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf0000c-95f3-4a4d-830b-f5ac1539823d

See also:

Related medical questions

Drug information

Related support groups